Kuczyńska Monika, Jakubek Patrycja, Bartoszek Agnieszka
Faculty of Chemistry, Gdańsk University of Technology, 80-233 Gdańsk, Poland.
Antioxidants (Basel). 2022 Dec 4;11(12):2403. doi: 10.3390/antiox11122403.
The concept of oxidative stress as a condition underlying a multitude of human diseases has led to immense interest in the search for antioxidant-based remedies. The simple and intuitive story of "the bad" reactive oxygen species (ROS) and "the good" antioxidants quickly (and unsurprisingly) lead to the commercial success of products tagged "beneficial to health" based solely on the presence of antioxidants. The commercial success of antioxidants by far preceded the research aimed at understanding the exact redox-related mechanisms that are in control of shaping the states of health and disease. This review describes the redox network formed by the interplay of ROS with cellular molecules and the resulting regulation of processes at the genomic and proteomic levels. Key players of this network are presented, both involved in redox signalling and control of cellular metabolism linked to most, if not all, physiological processes. In particular, this review focuses on the concept of reductive stress, which still remains less well-established compared to oxidative stress.
氧化应激作为多种人类疾病潜在病因的概念,引发了人们对寻找基于抗氧化剂的治疗方法的极大兴趣。关于“有害的”活性氧(ROS)和“有益的”抗氧化剂这种简单直观的说法,很快(且不出所料地)促成了仅因含有抗氧化剂就被贴上“有益健康”标签的产品在商业上的成功。抗氧化剂在商业上的成功远远早于旨在理解控制健康与疾病状态的确切氧化还原相关机制的研究。本综述描述了由ROS与细胞分子相互作用形成的氧化还原网络,以及由此在基因组和蛋白质组水平对各种过程的调控。介绍了该网络的关键参与者,它们既参与氧化还原信号传导,又控制与大多数(即便不是全部)生理过程相关的细胞代谢。特别是,本综述重点关注还原应激的概念,与氧化应激相比,还原应激仍未得到充分确立。